DAL’s 5.2% Drop: Weak Earnings, Not a Clear Bargain

I see the −5.17% move to $86.60 as understandable against deteriorating recent earnings, not enough evidence to call it an overreaction. Q3 revenue rose 21.1% to $20,186M, but net income fell 46.6% to $756M, EPS dropped 47.0% to $1.15 and free cash flow declined 56.4% to $300M. Estimates also imply 2026 EPS down 30.1% to $5.351 before a highly uncertain 36.3% rebound to $7.295 in 2027. At 16.2x estimated 2026 earnings and 11.9x 2027, the forward valuation looks less demanding, but the 18.1x trailing multiple and 50.0% 12-month rally offer little margin of safety. The fall does not change my cautious view; with no DAL position, I stay out and wait for stronger earnings evidence or a better price.